Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-144,200
Closed -$190K 5949
2025
Q4
$190K Buy
+144,200
New +$181K ﹤0.01% 5488
2025
Q2
Sell
-355,700
Closed -$566K 6024
2025
Q1
$566K Buy
+355,700
New +$866K ﹤0.01% 4732
2024
Q3
Sell
-114,500
Closed -$485K 6230
2024
Q2
$485K Buy
+114,500
New +$446K ﹤0.01% 4614
2018
Q3
Sell
-350,000
Closed -$1.2M 4034
2018
Q2
$1.2M Buy
+350,000
New +$1.34M ﹤0.01% 2723
2017
Q1
Sell
-300,000
Closed -$621K 3608
2016
Q4
$621K Buy
+300,000
New +$633K ﹤0.01% 2551

Other funds holding GERN

Israel Englander's GERN Position: Q2 2026 in Review

Israel Englander increased its Geron (GERN) stake by 11% in Q2 2026, buying an estimated $1.11M and bringing the position to 8,112,267 shares worth $10.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2243.

Israel Englander first reported a position in GERN in Q3 2013 and has held it in 47 quarters since. The position peaked at $39.2M in Q2 2023. 258 funds tracked by Wall St. Rank hold GERN as of Q2 2026.

  • Israel Englander held 8,112,267 shares of Geron worth $10.4M as of Q2 2026.
  • Israel Englander bought 790,745 Geron shares in Q2 2026, an estimated $1.11M.
  • Geron made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2243 holding.
  • Israel Englander first reported a position in Geron in Q3 2013 and has held it in 47 quarters since.
  • Israel Englander's Geron position peaked at $39.2M in Q2 2023.
  • 258 funds tracked by Wall St. Rank held Geron as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.